Home
GRAL
GRAL News

Latest GRAIL INC (GRAL) News on December 23, 2024

GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference

PR Newswire

5 days ago

GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference

What's Going On With Illumina Stock On Monday?

Benzinga

7 days ago

What's Going On With Illumina Stock On Monday?

One Of IBD's Best Screens Identifies These Four Market Leaders, Including Garmin, Ollie's

Investor's Business Daily

13 days ago

One Of IBD's Best Screens Identifies These Four Market Leaders, Including Garmin, Ollie's

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire

20 days ago

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

MT Newswires

a month ago

Grail 1st-Mover Advantage Faces Regulatory Hurdles in Multi-Cancer Detection, Morgan Stanley Says

MT Newswires

a month ago

Grail Insider Sold Shares Worth $426,937, According to a Recent SEC Filing

GRAIL to Participate in Upcoming Investor Conferences

PR Newswire

a month ago

GRAIL to Participate in Upcoming Investor Conferences

MT Newswires

a month ago

GRAIL Says First Person Tested With Blood-Based Assay in Lung Cancer Trial

GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study

PR Newswire

a month ago

GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study

Is Illumina, Inc. (ILMN) the Best Immunotherapy Stock to Buy Now?

Insider Monkey

a month ago

Is Illumina, Inc. (ILMN) the Best Immunotherapy Stock to Buy Now?

GuruFocus.com

a month ago

GRAIL Inc (GRAL) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...

GRAIL Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

a month ago

GRAIL Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

GRAIL Reports Third Quarter 2024 Financial Results

PR Newswire

a month ago

GRAIL Reports Third Quarter 2024 Financial Results

GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

PR Newswire

2 months ago

GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

GRAIL to Announce Third Quarter 2024 Financial Results

PR Newswire

2 months ago

GRAIL to Announce Third Quarter 2024 Financial Results

GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference

PR Newswire

2 months ago

GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference

GRAIL Appoints Sarah Krevans to Board of Directors

PR Newswire

2 months ago

GRAIL Appoints Sarah Krevans to Board of Directors

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 10/18/2024

GRAIL, Inc. (GRAL): Jeff Bezos Is Buying This Stock Now

Insider Monkey

2 months ago

GRAIL, Inc. (GRAL): Jeff Bezos Is Buying This Stock Now

CRCM LP's Strategic Acquisition of GRAIL Inc Shares

GuruFocus.com

3 months ago

CRCM LP's Strategic Acquisition of GRAIL Inc Shares

We're Keeping An Eye On GRAIL's (NASDAQ:GRAL) Cash Burn Rate

Simply Wall St.

3 months ago

We're Keeping An Eye On GRAIL's (NASDAQ:GRAL) Cash Burn Rate

Illumina Wins Court Fight With EU Over $7 Billion Grail Deal

Bloomberg

4 months ago

Illumina Wins Court Fight With EU Over $7 Billion Grail Deal

MT Newswires

4 months ago

Illumina Wins Jurisdictional Appeal in Europe Over GRAIL Acquisition

GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4)

PR Newswire

4 months ago

GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4)

Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology

PR Newswire

4 months ago

Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology

MT Newswires

4 months ago

Grail Insider Sold Shares Worth $1,203,650, According to a Recent SEC Filing

MT Newswires

4 months ago

Grail Insider Sold Shares Worth $254,121, According to a Recent SEC Filing

GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

PR Newswire

4 months ago

GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

Grail to shed 350 workers in restructuring

MedTech Dive

4 months ago

Grail to shed 350 workers in restructuring

MT Newswires

4 months ago

Grail Q2 Net Loss Widens, Revenue Rises; Cost Cuts Planned; Shares Jump After Hours

GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update

PR Newswire

4 months ago

GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update

Wheels Up Announces Gregory Summe to Join Board of Directors

PR Newswire

4 months ago

Wheels Up Announces Gregory Summe to Join Board of Directors

GRAIL to Announce Second Quarter 2024 Financial Results

PR Newswire

5 months ago

GRAIL to Announce Second Quarter 2024 Financial Results

Here’s Why You Should Add Illumina (ILMN) to Your Portfolio

Insider Monkey

5 months ago

Here’s Why You Should Add Illumina (ILMN) to Your Portfolio

Grail announces first patients enrolled in REACH cancer trial

Medical Device Network

5 months ago

Grail announces first patients enrolled in REACH cancer trial

GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri® Multi-Cancer Early Detection (MCED) Test in the Medicare Population

PR Newswire

5 months ago

GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri® Multi-Cancer Early Detection (MCED) Test in the Medicare Population

MT Newswires

5 months ago

Sector Update: Health Care Stocks Edge Higher Premarket Monday

MT Newswires

5 months ago

Grail Completes Enrollment in US Study for Cancer Early-Detection Device

GRAIL Advances the Galleri® Registrational Clinical Trial Program

PR Newswire

5 months ago

GRAIL Advances the Galleri® Registrational Clinical Trial Program

Share on Social Networks: